Samsung Bioepis Initiates Phase 3 Clinical Trial for SB27,
INCHEON, Korea, April 05, 2024 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. today announced the initiation of Phase 3 clinical ...
Read moreINCHEON, Korea, April 05, 2024 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. today announced the initiation of Phase 3 clinical ...
Read moreInterchangeability study for HADLIMA (adalimumab-bwwd) was conducted in accordance with the FDA’s Guidance for Industry; primary pharmacokinetics (PK) endpoints as ...
Read more09 February 2024 - Worldwide Olympic Partner Samsung Electronics Co., Ltd has added to the excitement surrounding the upcoming Olympic and Paralympic ...
Read moreMISSISSAUGA, Ontario, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Samsung Electronics Canada today announced that the new Samsung Galaxy S24 Series, ...
Read moreMISSISSAUGA, Ontario, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Samsung Electronics Canada today unveiled the Samsung Galaxy S24 Ultra, Samsung Galaxy ...
Read moreReport highlights latest biosimilar pricing and market share status, including state of the adalimumab marketBiosimilar Deep Dive section illustrates patient ...
Read moreHyundai Motor and Kia will link Samsung’s ‘SmartThings’ IoT (Internet of Things) platform to their connected car servicesThe three companies ...
Read moreHyundai Motor and Kia will link Samsung’s ‘SmartThings’ IoT (Internet of Things) platform to their connected car servicesThe three companies ...
Read moreHighlights Cadence Tempus Timing Solution and Quantus Extraction Solution enabled Samsung Foundry to confidently sign off their SF5A design while ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.